A Study to Demonstrate the Efficacy and Safety of Adapalene/Benzoyl Peroxide Topical Gel in Subjects With Acne Vulgaris
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT00421993|
Recruitment Status : Completed
First Posted : January 15, 2007
Results First Posted : March 11, 2009
Last Update Posted : October 20, 2009
|Study Design||Allocation: Randomized; Intervention Model: Parallel Assignment; Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor); Primary Purpose: Treatment|
Drug: Adapalene/Benzoyl Peroxide
Drug: Benzoyl Peroxide
Drug: Topical Gel Vehicle
Recruitment period: First Subject Enrolled October 2006, Last Subject Enrolled July 2007.
Types of locations: Dermatology Clinics, Dermatology Research Centers.
|Pre-assignment Details||The specified washout period up to Baseline for TOPICAL facial treatments was 1 week (light therapy/exfoliation/blackhead removal) or 2 weeks (anti-inflammatory drugs/salicylic acid/steroids/antibiotics/laser) and for SYSTEMIC medications was 2 weeks (anti-inflammatory drugs), 4 Weeks (steroids/antibiotics), or 6 months (anti-acne/contraceptives).|